Erratum: Comparing methodological quality and consistency of international guidelines for the management of patients with chronic heart failure (European Journal of Heart Failure (2003) 5 (327-335) DOI: 10.1016/S1388-9842(03)00040-0);Comparing methodological quality and consistency of international guidelines for the management of patients with chronic heart failure

European Journal of Heart Failure

Volumn 5, Issue 3, 2003, Pages 327-335

  Kulig, Michael ^a   Erika, Schulte ^a   Norbert, Willich Stefan ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Appraisal instrument; Guideline; Heart failure; Methodological quality

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; AMLODIPINE; ANGIOTENSIN II ANTAGONIST; ANTIARRHYTHMIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; HYDRALAZINE; ISOSORBIDE DINITRATE; SPIRONOLACTONE;

ARTICLE; DATA BASE; DEFIBRILLATOR; DIAGNOSTIC TEST; EXERCISE; HEALTH CARE QUALITY; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INTERNET; MEDICAL LITERATURE; METHODOLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SODIUM RESTRICTION;

EID: 0041940200     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.04.016     Document Type: Erratum

References (37)

1. McDonagh TA, Morrison CE, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-33.
2. Clarke KW, Gray D, Hampton JR. How common is heart failure? Evidence from PACT (prescribing analysis and cost) data in Nottingham. J Public Health Med 1995;17(4):459-64.
3. Schocken D, Arrieta M, Leaverton P, Ross E. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
4. Gardin JM, Siscovick D, AntonCulver H, et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 1995;91(6):1739-48.
5. Dargie HJ, McMurray JJ, McDonagh TA. Heart failure - implications of the true size of the problem. J Intern Med 1996;234(4):309-15.
6. Ryden-Bergsten T, Andersson F. The health care costs of heart failure in Sweden. J Intern Med 1999;246(3):275-84.
7. Szucs TD, Sokolovic E. Economic significance of heart failure. An overview of costs and economics of therapy. Herz 2000;25(5):538-46.
8. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002 June;4(3):361-71.
9. Levy E. From cost of illness to cost-effectiveness in heart failure. Eur Heart J 1998;19 (Suppl.):2-4.
10. O'Connell JB. The economic burden of heart failure. Clin Cardiol 2000;23(3 (Supl.)):6-10.
11. Hobbs FD. Primary care physicians: champions of or an impediment to optimal care of the patient with heart failure? Eur J Heart Fail 1999;1(1):11-5.
12. Van Veldhuisen DJ, Charlesworth A, Crijns HJ, Lie KI, Hampton JR. Differences in drug treatment of chronic heart failure between European countries. Eur Heart J 1999;20(9):666-72.
13. Nohria A, Chen YT, Morton DJ, Walsh R, Vlasses PH, Krumholz HM. Quality of care for patients hospitalized with heart failure at academic medical centers. Am Heart J 1999;137(6):1028-34.
14. Gambassi G, Forman DE, Lapane KL, et al. Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group. Am Heart J 2000;139(1):85-93.
15. Gaspoz JM. Costs and benefits of heart failure treatment. Schweiz Med Wochenschr 1999;129(4):131-7.
16. Cluzeau FA, Littlejohns P. Appraising clinical practice guidelines in England and Wales: the development of a methodologic framework and its application to policy. Jt Comm J Qual Improv 1999;25(10):514-21.
17. Helou A, Lorenz W, Ollenschlager G, Reinauer H, Schwartz FW. Methodological standards of the evidence-based approach of clinical guidelines development in Germany. Consensus between the scientific community, self-governed bodies and practice. Z Arztl Fortbild Qualitatssich 2000;94(5):330-9.
18. National Guideline Clearinghouse, USA. Available from: http://www.guidelines.gov.
19. Bundesärztkammer, Kassenärztliche Bundesvereinigung. Beurteilungskriterien für Leitlinien in der medizinischen Versorgung. Dtsch Aerztebl 1997; 94: A2154-2155, B1622-1623, C1754-1755. English version: Evaluation Criteria for Clinical Practice Guidelines. Available from: http://www.azq.de.
20. Bundesärztkammer, Kassenärztliche Bundesvereinigung. Beurteilungskriterien für Leitlinien in der medizinischen Versorgung. Dtsch Aerztebl 1997; 94: A2154-2155, B1622-1623, C1754-1755. English version: Evaluation Criteria for Clinical Practice Guidelines. Available from: http://www.azq.de.
21. Scottish Intercollegiate Guidelines Network. Clinical Guidelines - Criteria for Appraisal for National Use. Available from: http://pc47.cee.hw.ac.uk/sign/critmain.html.
22. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281(20):1950-1.
23. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000;355:103-6.
24. Concise Guide to the Management of Heart Failure. World Health Organization/Council on Geriatric Cardiology Task Force on Heart Failure Education 1994.
25. Diagnosis and Treatment of Heart Failure due to Left Ventricular Systolic Dysfunction. Scottish Intercollegiate Guidelines Network 1999.
26. European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure. Eur Heart J 2001;22:1527-60 (W.J. Remme and K. Swedberg (Co-Chairmen)).
27. Leitlinien zur Therapie der chronischen Herzinsuffizienz. Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung. Z Kardiol 1998;97(8):645-658.
28. Heart Failure: Evaluation and Care of Patients with Left Ventricular Systolic Dysfunction. Agency of Health Care and Policy Research 1994.
29. Heart Failure. Clinical Practice Guideline. American Medical Directors Association 1996.
30. ACC/AHA Guidelines for the Evaluation of Management of Chronic Heart Failure in the Adult. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) 2001.
31. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the Advisory Council to improve outcomes nationwide in heart failure. Am J Cardiol 1999;83(2A):1A-38A.
32. Heart Failure Society of America (HFSA). Practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches. J Cardiac Fail 1999;5:357-82.
33. Management of Heart Failure. The College of Physicians & Surgeons of Manitoba (Canada) 1999.
34. A Guideline for the Management of Heart Failure. The National Heart Foundation of New Zealand, Cardiac Society of Australia and New Zealand and the Royal New Zealand College of General Practitioners Working Party 1997.
35. Cluzeau FA, Littlejohns P, Grimshaw JM, Feder G. Appraisal instrument for clinical guidelines. London: St. George's Hospital Medical School, 1997.
36. Helou A, Ollenschlager G. Goals, possibilities and limits of quality evaluation of guidelines. A background report on the user manual of the 'Methodological Quality of Guidelines' check list. Z Arztl Fortbild Qualitatssich 1998;92(5):361-5.
37. Cline CM, Isrealsson BY, Willenheimer RB, Broms K, Erhardt LR. Cost effective programme for heart failure reduces hospitalisation. Heart 1998;80(5):442-6.